Last €117.18 EUR
Change Today +0.174 / 0.15%
Volume 45.0
TN8 On Other Exchanges
Symbol
Exchange
New York
Stuttgart
Mexico
As of 7:39 AM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

thermo fisher scientific inc (TN8) Snapshot

Open
€116.83
Previous Close
€117.01
Day High
€117.20
Day Low
€116.71
52 Week High
03/3/15 - €117.20
52 Week Low
04/29/14 - €81.42
Market Cap
46.5B
Average Volume 10 Days
35.5
EPS TTM
--
Shares Outstanding
396.8M
EX-Date
03/12/15
P/E TM
--
Dividend
€0.60
Dividend Yield
0.39%
Current Stock Chart for THERMO FISHER SCIENTIFIC INC (TN8)

thermo fisher scientific inc (TN8) Details

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics worldwide. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables used in biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases. This segment serves pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for applications in the laboratory, on the production line, and in the field. It serves pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as the clinical laboratory. The company’s Specialty Diagnostics segment offers liquid, ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, and calibration verification fluids; blood-test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; and human leukocyte antigen typing and testing for the organ transplant market. This segment serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratory customers. Its Laboratory Products and Services segment offers sample preparation and preservation equipment, cold storage equipment, centrifugation products, biological safety cabinets, temperature control products, water analysis instruments, and other laboratory equipment, as well as laboratory consumables, research and safety market solutions, and biopharma services. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

51,000 Employees
Last Reported Date: 02/26/15
Founded in 1956

thermo fisher scientific inc (TN8) Top Compensated Officers

Chief Executive Officer, President, Director,...
Total Annual Compensation: $1.1M
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $653.7K
Executive Vice President and President of Lab...
Total Annual Compensation: $697.9K
Senior Vice President and President of Analyt...
Total Annual Compensation: $514.1K
Chief Commercial Officer and Senior Vice Pres...
Total Annual Compensation: $622.6K
Compensation as of Fiscal Year 2013.

thermo fisher scientific inc (TN8) Key Developments

Thermo Fisher Scientific Declares Quarterly Dividend, Payable on April 15, 2015

Thermo Fisher Scientific Inc. announced that its board of directors has declared a quarterly cash dividend of $0.15 per share. The dividend will be paid on April 15, 2015, to shareholders of record as of March 16, 2015.

Thermo Fisher Scientific, Inc. Presents at Biocom's Global Life Science Partnering Conference, Feb-25-2015

Thermo Fisher Scientific, Inc. Presents at Biocom's Global Life Science Partnering Conference, Feb-25-2015 . Venue: The Lodge at Torrey Pines, 11480 North Torrey Pines Road, La Jolla, CA 92037, United States.

Thermo Fisher Scientific, Inc. Announces Management Changes

Thermo Fisher Scientific, Inc. announced that Peter M. Wilver, senior vice president and chief financial officer, has decided to retire, effective March 31, 2016. The company's board of directors has elected Stephen Williamson, currently vice president of financial operations, as his successor, effective August 1, 2015. Williamson will report to Marc N. Casper, president and chief executive officer of Thermo Fisher. Wilver has led Thermo Fisher's global finance organization as CFO since 2004. He joined the company in 2000 as vice president of financial operations. Wilver will work with Williamson during the ensuing months to ensure a smooth transition of responsibilities, and will remain an active member of the Company Leadership Team until his retirement in March 2016. Williamson joined Thermo Fisher in July 2001 as vice president, European financial operations, based in the U.K., and subsequently served as the finance lead for the Informatics and Services, and Environmental Instruments businesses. He was named vice president of finance for Analytical Technologies in 2006, and two years later became vice president of financial operations for the company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TN8:GR €117.18 EUR +0.174

TN8 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Akzo Nobel NV €66.42 EUR -0.28
Corning Inc $24.59 USD -0.04
Danaher Corp $87.19 USD -0.28
General Dynamics Corp $137.13 USD -2.67
Safran SA €63.28 EUR -0.48
View Industry Companies
 

Industry Analysis

TN8

Industry Average

Valuation TN8 Industry Range
Price/Earnings 27.6x
Price/Sales 3.1x
Price/Book 2.5x
Price/Cash Flow 27.2x
TEV/Sales 2.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THERMO FISHER SCIENTIFIC INC, please visit www.thermofisher.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.